Tina Guanting Qiu is an accomplished ophthalmology physician, trained retinal surgeon, stem cell biologist, and ocular transplant specialist with over 20 years of international experience. She had led scientific research in drug discovery, sustained drug delivery, cell/gene therapy and artificial retina, established and led scientific and medical advisory boards, and served as a strategic advisor to executives in large and small companies (Inotek, GSK, Sucampo, Ocutx, LambdaVision, Ocata Therapeutic, GLG Management). She was Chief Medical Officer at BetaStem Inc., Senior Director at Inotekand Program Leader at GlaxoSmithKline. She has a Medical Doctor degree (with honors) from Nanchang University, a PhD in Ophthalmology from National Sun Yat-sen University in collaboration with Sheie Eye Institute, University of Pennsylvania followed by post-doctoral trainings at Boston University and Doheny Eye Institute, USC. She has invented, published and lectured across US, UK, Japan and China, and been featured at Scientific American and National Eye Research Center, UK (152 words).
Ophthalmic Therapeutic Innovation (Retina, Glaucoma, Ocular Surface & Cornea).